Accord Asks Appellate Judges To Nix Rival's Cancer Patent

Lawyers for Accord Healthcare urged the Court of Appeal at a hearing on Wednesday to nix remaining protections for blockbuster prostate cancer therapeutic Xtandi, saying the prior judge should not have...

Already a subscriber? Click here to view full article